je.st
news
Regeneron Pharmaceuticals PT Raised to $344.00
2013-12-22 08:42:25| Biotech - Topix.net
The firm currently has an "outperform" rating on the stock. RBC Capital's price target would indicate a potential upside of 23.43% from the company's current price.
Tags: raised
pharmaceuticals
regeneron
regeneron pharmaceuticals
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||